Gordan Lauc1, Marija Pezer2, Igor Rudan3, Harry Campbell3. 1. University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia; Genos Glycoscience Research Laboratory, Zagreb, Croatia. Electronic address: glauc@genos.hr. 2. Genos Glycoscience Research Laboratory, Zagreb, Croatia. 3. University of Edinburgh, School of Public Health Sciences, Edinburgh, Scotland, UK.
Abstract
BACKGROUND: The majority of human proteins are being modified by covalent attachment of complex oligosaccharides--glycans. Both glycans and polypeptide parts of a protein contribute to its structure and function, but contrary to polypeptide that is defined by the sequence of nucleotides in the corresponding gene, glycans are shaped by complex dynamic interactions between hundreds of enzymes, transcription factors, ion channels and other proteins. SCOPE OF REVIEW: An overview of current knowledge about the importance of N-glycans in normal human physiology and disease mechanisms, exemplified by IgG N-glycans. MAJOR CONCLUSIONS: Recent technological development enabled systematic analysis of glycome composition in large epidemiological cohorts and clinical studies. However, the majority of these studies is still missing any glycomic component, and consequently also lacks this layer of biological information. Individual variation in glycosylation is potentially important for individualized disease risk, disease course and response to therapy. Evidence in support of this hypothesis is accumulating, but further studies are needed to enable understanding of the role of changes in protein glycosylation in disease. GENERAL SIGNIFICANCE: Glycans are involved in virtually all physiological processes. Inter-individual variation in glycome composition is large, and these differences associate with disease risk, disease course and the response to therapy. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
BACKGROUND: The majority of human proteins are being modified by covalent attachment of complex oligosaccharides--glycans. Both glycans and polypeptide parts of a protein contribute to its structure and function, but contrary to polypeptide that is defined by the sequence of nucleotides in the corresponding gene, glycans are shaped by complex dynamic interactions between hundreds of enzymes, transcription factors, ion channels and other proteins. SCOPE OF REVIEW: An overview of current knowledge about the importance of N-glycans in normal human physiology and disease mechanisms, exemplified by IgG N-glycans. MAJOR CONCLUSIONS: Recent technological development enabled systematic analysis of glycome composition in large epidemiological cohorts and clinical studies. However, the majority of these studies is still missing any glycomic component, and consequently also lacks this layer of biological information. Individual variation in glycosylation is potentially important for individualized disease risk, disease course and response to therapy. Evidence in support of this hypothesis is accumulating, but further studies are needed to enable understanding of the role of changes in protein glycosylation in disease. GENERAL SIGNIFICANCE: Glycans are involved in virtually all physiological processes. Inter-individual variation in glycome composition is large, and these differences associate with disease risk, disease course and the response to therapy. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
Entities:
Keywords:
Glycosylation in disease; Human glycome; IgG glycosylation; Protein glycosylation
Authors: Alessandro T Caputo; Dominic S Alonzi; Lucia Marti; Ida-Barbara Reca; J L Kiappes; Weston B Struwe; Alice Cross; Souradeep Basu; Edward D Lowe; Benoit Darlot; Angelo Santino; Pietro Roversi; Nicole Zitzmann Journal: Proc Natl Acad Sci U S A Date: 2016-07-26 Impact factor: 11.205
Authors: Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic Journal: Biochim Biophys Acta Date: 2016-02-26
Authors: Shadi Ferdosi; Douglas S Rehder; Paul Maranian; Erik P Castle; Thai H Ho; Harvey I Pass; Daniel W Cramer; Karen S Anderson; Lei Fu; David E C Cole; Tao Le; Xifeng Wu; Chad R Borges Journal: J Proteome Res Date: 2017-11-21 Impact factor: 4.466
Authors: Mirna Šimurina; Noortje de Haan; Frano Vučković; Nicholas A Kennedy; Jerko Štambuk; David Falck; Irena Trbojević-Akmačić; Florent Clerc; Genadij Razdorov; Anna Khon; Anna Latiano; Renata D'Incà; Silvio Danese; Stephan Targan; Carol Landers; Marla Dubinsky; Dermot P B McGovern; Vito Annese; Manfred Wuhrer; Gordan Lauc Journal: Gastroenterology Date: 2018-01-06 Impact factor: 22.682
Authors: Sodbo Zh Sharapov; Yakov A Tsepilov; Lucija Klaric; Massimo Mangino; Gaurav Thareja; Alexandra S Shadrina; Mirna Simurina; Concetta Dagostino; Julia Dmitrieva; Marija Vilaj; Frano Vuckovic; Tamara Pavic; Jerko Stambuk; Irena Trbojevic-Akmacic; Jasminka Kristic; Jelena Simunovic; Ana Momcilovic; Harry Campbell; Margaret Doherty; Malcolm G Dunlop; Susan M Farrington; Maja Pucic-Bakovic; Christian Gieger; Massimo Allegri; Edouard Louis; Michel Georges; Karsten Suhre; Tim Spector; Frances M K Williams; Gordan Lauc; Yurii S Aulchenko Journal: Hum Mol Genet Date: 2019-06-15 Impact factor: 6.150